Analysis of a 1-Megabase Deletion in 15Q22-Q23 in an Autistic Patient

Total Page:16

File Type:pdf, Size:1020Kb

Analysis of a 1-Megabase Deletion in 15Q22-Q23 in an Autistic Patient American Journal of Medical Genetics (Neuropsychiatric Genetics) 96:765–770 (2000) Analysis of a 1-Megabase Deletion in 15q22-q23 in an Autistic Patient: Identification of Candidate Genes for Autism and of Homologous DNA Segments in 15q22-q23 and 15q11-q13 Moyra Smith,* Pauline A. Filipek, Charles Wu, Maureen Bocian, Simin Hakim, Charlotte Modahl, and M. Anne Spence Department of Pediatrics, University of California, Irvine, California We have identified a one megabase deletion sequences or to non-coding homologous in the 15q22-15q23 region in a patient with DNA sequences. The PTPN9 gene encodes a autism, developmental delay, and mild dys- non-receptor protein tyrosine phosphatase. morphism. Genes that map within the dele- The Slp-1 [hUNC24] gene is expressed tion region and genes that are interrupted mainly in the brain. Am. J. Med. Genet. or rearranged at the deletion breakpoints (Neuropsychiatr. Genet.) 96:765–770, 2000. are candidate genes for autism. Fluroes- © 2000 Wiley-Liss, Inc. cence in situ hybridization studies in this patient revealed that part or all of the PML KEY WORDS: autism; 15q22-q23; 15q11-q13; gene is absent from one chromosome 15 and PTPN9; SLP-1[hUNC24] a BAC clone containing the D15S124 gene locus hybridizes to only one chromosome 15. BAC clones containing the PTPN9, and INTRODUCTION SLP-1[hUNC24] genes showed markedly re- duced hybridization in the 15q22-q23 region Autism is characterized by impairments in reciprocal on one chromosome 15 in the patient. These social interaction and communication, restricted and BACs also hybridize to the 15q11-q13 region stereotyped patterns of interests and activities, and the in close proximity to SNRPN and HERC2, presence of developmental abnormalities by 3 years of and in this region there is equal intensity of age [Bailey et al., 1996]. Autism most likely represents signal on the normal and on the deleted a genetically heterogeneous condition. There is evi- chromosome. There are previous reports of dence from linkage studies [Bass et al., 1998] and from deletions and duplications of the 15q11-q13 cytogenetic studies [Steffenburg et al., 1996; Schroer et region in patients with autism. Our patient al., 1998] that a locus on chromosome15q11-15q13 represents the first report of a 15q22-q23 de- plays a role in the development of autism. Schroer et al. letion. Hybridization of the PTPN9 and [1998] proposed that the GABA receptor A genes and Slp-1 Bac clones to the 15q11-q13 and the the UBE3A gene represent candidates for autism. We 15q22-q23 regions of chromosome 15 may be undertook an analysis of chromosome 15 gene loci by due to the presence of PTPN9 or SLP-1 gene fluorescence in situ hybridization (FISH) in a patient sequences or to the presence of other gene with autism, developmental delay, and mild dysmor- phology who exhibited a number of features suggestive of Angelman syndrome. The results of high-resolution karyotype analysis were normal. The Angelman region fluorescence in situ hybridization; was examined by FISH using SNRPN and GABRB3 ס Abbreviations: FISH probes, each in combination with the PML gene as a ס National Center for Biotechnical Information; PCR ס NCBI polymerase chain reaction. control probe for chromosome 15. SNRPN and Contract grant sponsor: National Institute of Child Health and GABRB3 genes mapped to the 15q11-q13 region and Human Development (NICHD); Contract grant number: HD yielded normal signals. The PML gene probe hybrid- 35458 (M.A. Spence, principal investigator); Contract grant spon- sor: Funds from the National Alliance for Autism; Contract grant ized to only one member of the chromosome 15 pair. number: 26165 (Moyra Smith, principal investigator). This finding indicated that there was a deletion in the *Correspondence to: Moyra Smith, Department of Pediatrics, chromosome 15q22-q23 region. Further studies were Medical Sciences 1, Room C214, University of California, Irvine, undertaken to define the extent of the deletion, to rule CA 92697. E-mail: [email protected] out the occurrence of uniparental disomy, and to exam- Received 26 January 2000; Accepted 13 March 2000 ine the SNRPN methylation status to determine © 2000 Wiley-Liss, Inc. 766 Smith et al. whether imprinting defects were present. This is the The following tests revealed no abnormalities: brain- first report of a deletion in the 15q22-q23 region in a stem auditory evoked potentials, computed tomogra- patient with autism. It is likely that the autistic behav- phy scan, creatine phosphokinase levels, routine high- iors in our patient are due to the absence of one copy of resolution karyotype, DNA for fragile-X syndrome, a specific gene or genes (haploinsufficiency) or to the sleep-deprived electroencephalography, free/total/acyl interruption or rearrangement of specific genes within carnitine profile, quantitative serum amino acids, lac- the breakpoint regions. Genes that map within the de- tate, pyruvate, and urine organic acids. Physical and letion region on 15q22-q23 and genes that map at the dysmorphology examinations at 7 years of age revealed deletion breakpoint region therefore represent candi- a height in the 10th percentile, weight in the 5th per- date genes for autism. We identified a series of over- centile, and head circumference at 50th percentile. The lapping BAC clones that map in the distal breakpoint patient (Fig. 1a) has blond hair, light blue lacy irises, region of the deletion in our patient. These overlapping and skin, hair, and eye color much lighter than that of BACs, which contain the sequence of two different the parents. She has a long, narrow face, slightly flat genes, PTPN9, and SLP-1, the human homolog of the occiput with no horizontal groove, minimal epicanthal Caenorhabditis elegans UNC24 gene, hybridize to the folds, slightly concave nasal base and bridge, thin up- 15q22-q23 region and to the 15q11-q13 region. This per lip, normal mouth width, wide dental spacing in finding indicates that homologous DNA sequences ex- the upper jaw, narrow anterior palate with broad lat- ist in the 15q22-q23 region, which is deleted in our eral palatine ridges, relatively prominent pointed chin, patient with autism, and in the 15q11-q13 region, mild pectus excavatum, poor muscular contours of which has been shown to be duplicated deleted or in- thighs and calves, flat nails, lax fingers, and somewhat verted in other cases of autism that have been reported transparent skin on chest and shoulders. The patient is in the literature [Bundey et al, 1994; Steffenburg et al., hypotonic, and deep tendon reflexes are brisk. She 1996; Cook et al., 1997]. walks with an immature gait, often with her arms in an uplifted flexed position. She has occasional episodes of hand flapping and intermittent episodes of excessive CLINICAL REPORT chewing and mouthing behaviors and teeth grinding. The mother was a 37-year-old gravida 3 woman, and There is no tongue protrusion, no excessive smiling, pregnancy was uneventful with no teratogenic expo- and no unprovoked outbursts of laughter. The child has sures. This infant was delivered at term by cesarean frequent infections. The results of a complete develop- section for possible fetal distress, with a birth weight of mental and neuropsychological evaluation, and a quan- 6 pounds 13 ounces. Hypotonia and severe global de- titative brain magnetic resonance imaging scan will be velopmental delay were evident by 6 to 12 months: the presented elsewhere (Filipek et al., unpublished manu- child sat at 10 months, crawled at 20 months, and script). walked at 26 to 29 months. She developed at least seven spontaneous words after 18 months, had good METHODS AND RESULTS eye contact, pointed, and waved bye-bye, before losing all of these skills by 29 months of age. Evaluation for suspected autism was carried out at 4.2 years of age, Cultured lymphoblastoid cell lines were used to pre- when she was evaluated as meeting the criteria for pare slides with metaphase spreads and interphase nu- autistic disorder by the DSM-IV, the Autism Diagnos- clei. FISH was carried out by standard techniques. tic Interview- Revised [Lord et al., 1994], and the Au- Probes for FISH included commercially available tism Diagnostic Observation Schedule-Generic [Lord et probes from Oncor, Gaithersburg, MD [GABRB3/PML al., 1989]. The Autism Diagnostic Interview algorithm and SNRPN/PML] and Vysis, Downer’s Grove, IL [SN- scores are presented in Table I. The child’s medical RPN and PML/RARA]. We isolated a series of BAC history is significant for a lack of feeding problems, clones for loci in the 15q22-q23 region [National Center excessive drooling, sleep disturbance, hypermotoric be- for Biotechnology Information (NCBI), 1999]. BAC havior, gait ataxia, or seizures. The infant was noted to clones corresponding to D15S124 and D15S160 genes have strabismus, which was treated by eye patching. were isolated by screening BAC libraries with oligo- nucleotide primers corresponding to these loci. BAC clones containing sequences corresponding to the genes TABLE I. Algorithm Scores for the Autism TLE3, PTPN9, PML, SLP1(hUNC24), CHRNA5, and Diagnostic Interview ETFA were identified by searching for genomic DNA Patient Autism clones with matching sequences in the NCBI genome Categories score cutoffa survey sequence database. BAC clones thus identified were ordered from Research Genetics, Huntsville, AL. Qualitative impairment of reciprocal social interaction 20 10 Individual BAC clones were cultured, and DNA was Impairment of communication 14 7 isolated and used for polymerase chain reaction (PCR) Repetitive behaviors and to confirm that each BAC clone was positive for the stereotyped patterns 7 3 corresponding gene sequences. Purified BAC DNA was Abnormal development labeled with spectrum green or spectrum orange (Vy- evident before 36 months 5 1 sis), using the Vysis labeling system. Labeled BAC aNote that scores at or above the cutoff indicate autism DNA was hybridized to human Cot 1 DNA to block Analysis of 1Mb Deletion in 15q22-q23 in an Autistic Patient 767 Fig.
Recommended publications
  • UNIVERSITY of CALIFORNIA, SAN DIEGO Functional Analysis of Sall4
    UNIVERSITY OF CALIFORNIA, SAN DIEGO Functional analysis of Sall4 in modulating embryonic stem cell fate A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Molecular Pathology by Pei Jen A. Lee Committee in charge: Professor Steven Briggs, Chair Professor Geoff Rosenfeld, Co-Chair Professor Alexander Hoffmann Professor Randall Johnson Professor Mark Mercola 2009 Copyright Pei Jen A. Lee, 2009 All rights reserved. The dissertation of Pei Jen A. Lee is approved, and it is acceptable in quality and form for publication on microfilm and electronically: ______________________________________________________________ ______________________________________________________________ ______________________________________________________________ ______________________________________________________________ Co-Chair ______________________________________________________________ Chair University of California, San Diego 2009 iii Dedicated to my parents, my brother ,and my husband for their love and support iv Table of Contents Signature Page……………………………………………………………………….…iii Dedication…...…………………………………………………………………………..iv Table of Contents……………………………………………………………………….v List of Figures…………………………………………………………………………...vi List of Tables………………………………………………….………………………...ix Curriculum vitae…………………………………………………………………………x Acknowledgement………………………………………………….……….……..…...xi Abstract………………………………………………………………..…………….....xiii Chapter 1 Introduction ..…………………………………………………………………………….1 Chapter 2 Materials and Methods……………………………………………………………..…12
    [Show full text]
  • Analysis of the Indacaterol-Regulated Transcriptome in Human Airway
    Supplemental material to this article can be found at: http://jpet.aspetjournals.org/content/suppl/2018/04/13/jpet.118.249292.DC1 1521-0103/366/1/220–236$35.00 https://doi.org/10.1124/jpet.118.249292 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS J Pharmacol Exp Ther 366:220–236, July 2018 Copyright ª 2018 by The American Society for Pharmacology and Experimental Therapeutics Analysis of the Indacaterol-Regulated Transcriptome in Human Airway Epithelial Cells Implicates Gene Expression Changes in the s Adverse and Therapeutic Effects of b2-Adrenoceptor Agonists Dong Yan, Omar Hamed, Taruna Joshi,1 Mahmoud M. Mostafa, Kyla C. Jamieson, Radhika Joshi, Robert Newton, and Mark A. Giembycz Departments of Physiology and Pharmacology (D.Y., O.H., T.J., K.C.J., R.J., M.A.G.) and Cell Biology and Anatomy (M.M.M., R.N.), Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada Received March 22, 2018; accepted April 11, 2018 Downloaded from ABSTRACT The contribution of gene expression changes to the adverse and activity, and positive regulation of neutrophil chemotaxis. The therapeutic effects of b2-adrenoceptor agonists in asthma was general enriched GO term extracellular space was also associ- investigated using human airway epithelial cells as a therapeu- ated with indacaterol-induced genes, and many of those, in- tically relevant target. Operational model-fitting established that cluding CRISPLD2, DMBT1, GAS1, and SOCS3, have putative jpet.aspetjournals.org the long-acting b2-adrenoceptor agonists (LABA) indacaterol, anti-inflammatory, antibacterial, and/or antiviral activity. Numer- salmeterol, formoterol, and picumeterol were full agonists on ous indacaterol-regulated genes were also induced or repressed BEAS-2B cells transfected with a cAMP-response element in BEAS-2B cells and human primary bronchial epithelial cells by reporter but differed in efficacy (indacaterol $ formoterol .
    [Show full text]
  • Primepcr™Assay Validation Report
    PrimePCR™Assay Validation Report Gene Information Gene Name Transducin-like enhancer protein 3 Gene Symbol Tle3 Organism Rat Gene Summary may be involved in transcription regulation in the CNS both during development and in the adult Gene Aliases Not Available RefSeq Accession No. NM_053400 UniGene ID Rn.24106 Ensembl Gene ID ENSRNOG00000013013 Entrez Gene ID 84424 Assay Information Unique Assay ID qRnoCID0007306 Assay Type SYBR® Green Detected Coding Transcript(s) ENSRNOT00000018467 Amplicon Context Sequence TATGAGATGTCCTACGGCTTGAATATCGAAATGCACAAGCAGACAGAGATCGCG AAGAGACTGAACACGATTCTAGCCCAGATCATGCCTTTTTTGTCA Amplicon Length (bp) 69 Chromosome Location 8:66041636-66059306 Assay Design Intron-spanning Purification Desalted Validation Results Efficiency (%) 98 R2 0.9996 cDNA Cq 20.98 cDNA Tm (Celsius) 80 gDNA Cq 44.24 Specificity (%) 100 Information to assist with data interpretation is provided at the end of this report. Page 1/4 PrimePCR™Assay Validation Report Tle3, Rat Amplification Plot Amplification of cDNA generated from 25 ng of universal reference RNA Melt Peak Melt curve analysis of above amplification Standard Curve Standard curve generated using 20 million copies of template diluted 10-fold to 20 copies Page 2/4 PrimePCR™Assay Validation Report Products used to generate validation data Real-Time PCR Instrument CFX384 Real-Time PCR Detection System Reverse Transcription Reagent iScript™ Advanced cDNA Synthesis Kit for RT-qPCR Real-Time PCR Supermix SsoAdvanced™ SYBR® Green Supermix Experimental Sample qPCR Reference Total RNA Data Interpretation Unique Assay ID This is a unique identifier that can be used to identify the assay in the literature and online. Detected Coding Transcript(s) This is a list of the Ensembl transcript ID(s) that this assay will detect.
    [Show full text]
  • Identification of Differentially Expressed Genes in Human Bladder Cancer Through Genome-Wide Gene Expression Profiling
    521-531 24/7/06 18:28 Page 521 ONCOLOGY REPORTS 16: 521-531, 2006 521 Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling KAZUMORI KAWAKAMI1,3, HIDEKI ENOKIDA1, TOKUSHI TACHIWADA1, TAKENARI GOTANDA1, KENGO TSUNEYOSHI1, HIROYUKI KUBO1, KENRYU NISHIYAMA1, MASAKI TAKIGUCHI2, MASAYUKI NAKAGAWA1 and NAOHIKO SEKI3 1Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520; Departments of 2Biochemistry and Genetics, and 3Functional Genomics, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan Received February 15, 2006; Accepted April 27, 2006 Abstract. Large-scale gene expression profiling is an effective CKS2 gene not only as a potential biomarker for diagnosing, strategy for understanding the progression of bladder cancer but also for staging human BC. This is the first report (BC). The aim of this study was to identify genes that are demonstrating that CKS2 expression is strongly correlated expressed differently in the course of BC progression and to with the progression of human BC. establish new biomarkers for BC. Specimens from 21 patients with pathologically confirmed superficial (n=10) or Introduction invasive (n=11) BC and 4 normal bladder samples were studied; samples from 14 of the 21 BC samples were subjected Bladder cancer (BC) is among the 5 most common to microarray analysis. The validity of the microarray results malignancies worldwide, and the 2nd most common tumor of was verified by real-time RT-PCR. Of the 136 up-regulated the genitourinary tract and the 2nd most common cause of genes we detected, 21 were present in all 14 BCs examined death in patients with cancer of the urinary tract (1-7).
    [Show full text]
  • Gene Expression Profiling of Human Sarcomas: Insights Into Sarcoma Biology
    Research Article Gene Expression Profiling of Human Sarcomas: Insights into Sarcoma Biology Kristin Baird,1 Sean Davis,1 Cristina R. Antonescu,3 Ursula L. Harper,1 Robert L. Walker,1 Yidong Chen,1 Arthur A. Glatfelter,1 Paul H. Duray,2 and Paul S. Meltzer1 1Cancer Genetics Branch, National Human Genome Research Institute; 2Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, Maryland; 3Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York Abstract changes. This latter group occurs more frequently in older adults and includes several types of sarcomas that lack known disease- Sarcomas are a biologically complex group of tumors of specific chromosome translocations or mutations, but may contain mesenchymal origin. By using gene expression microarray mutations in RB1, CDKN2A, and TP53. Investigation of these and analysis, we aimed to find clues into the cellular differenti- other aspects of sarcoma biology have provided insights into ation and oncogenic pathways active in these tumors as well broadly relevant fundamental mechanisms of oncogenesis (for as potential biomarkers and therapeutic targets. We exam- review, see ref. 1) and may have profound implications in the ined 181 tumors representing 16 classes of human bone and development of therapeutic intervention. This is exemplified by the soft tissue sarcomas on a 12,601-feature cDNA microarray. successful treatment of gastrointestinal stromal tumors, which Remarkably, 2,766 probes differentially expressed across this frequently have activating mutations of KIT, with the tyrosine sample set clearly delineated the various tumor classes. kinase inhibitor, imatinib mesylate. Although genetic alterations, Several genes of potential biological and therapeutic interest particularly fusion genes arising from translocations, have been were associated with each sarcoma type, including specific identified in many sarcomas, the function of the fusion gene tyrosine kinases, transcription factors, and homeobox genes.
    [Show full text]
  • Using Structural Knowledge in the Protein Data Bank to Inform The
    Mahajan and Mande BMC Bioinformatics (2017) 18:201 DOI 10.1186/s12859-017-1550-y RESEARCH ARTICLE Open Access Using structural knowledge in the protein data bank to inform the search for potential host-microbe protein interactions in sequence space: application to Mycobacterium tuberculosis Gaurang Mahajan1,2* and Shekhar C. Mande1 Abstract Background: A comprehensive map of the human-M. tuberculosis (MTB) protein interactome would help fill the gaps in our understanding of the disease, and computational prediction can aid and complement experimental studies towards this end. Several sequence-based in silico approaches tap the existing data on experimentally validated protein-protein interactions (PPIs); these PPIs serve as templates from which novel interactions between pathogen and host are inferred. Such comparative approaches typically make use of local sequence alignment, which, in the absence of structural details about the interfaces mediating the template interactions, could lead to incorrect inferences, particularly whenmulti-domainproteinsareinvolved. Results: We propose leveraging the domain-domain interaction (DDI) information in PDB complexes to score and prioritize candidate PPIs between host and pathogen proteomes based on targeted sequence-level comparisons. Our method picks out a small set of human-MTB protein pairs as candidates for physical interactions, and the use of functional meta-data suggests that some of them could contribute to the in vivo molecular cross-talk between pathogen and host that regulates the course of the infection. Further, we present numerical data for Pfam domain families that highlights interaction specificity on the domain level. Not every instance of a pair of domains, for which interaction evidence has been found in a few instances (i.e.
    [Show full text]
  • Newly Identified Gon4l/Udu-Interacting Proteins
    www.nature.com/scientificreports OPEN Newly identifed Gon4l/ Udu‑interacting proteins implicate novel functions Su‑Mei Tsai1, Kuo‑Chang Chu1 & Yun‑Jin Jiang1,2,3,4,5* Mutations of the Gon4l/udu gene in diferent organisms give rise to diverse phenotypes. Although the efects of Gon4l/Udu in transcriptional regulation have been demonstrated, they cannot solely explain the observed characteristics among species. To further understand the function of Gon4l/Udu, we used yeast two‑hybrid (Y2H) screening to identify interacting proteins in zebrafsh and mouse systems, confrmed the interactions by co‑immunoprecipitation assay, and found four novel Gon4l‑interacting proteins: BRCA1 associated protein‑1 (Bap1), DNA methyltransferase 1 (Dnmt1), Tho complex 1 (Thoc1, also known as Tho1 or HPR1), and Cryptochrome circadian regulator 3a (Cry3a). Furthermore, all known Gon4l/Udu‑interacting proteins—as found in this study, in previous reports, and in online resources—were investigated by Phenotype Enrichment Analysis. The most enriched phenotypes identifed include increased embryonic tissue cell apoptosis, embryonic lethality, increased T cell derived lymphoma incidence, decreased cell proliferation, chromosome instability, and abnormal dopamine level, characteristics that largely resemble those observed in reported Gon4l/udu mutant animals. Similar to the expression pattern of udu, those of bap1, dnmt1, thoc1, and cry3a are also found in the brain region and other tissues. Thus, these fndings indicate novel mechanisms of Gon4l/ Udu in regulating CpG methylation, histone expression/modifcation, DNA repair/genomic stability, and RNA binding/processing/export. Gon4l is a nuclear protein conserved among species. Animal models from invertebrates to vertebrates have shown that the protein Gon4-like (Gon4l) is essential for regulating cell proliferation and diferentiation.
    [Show full text]
  • Downloaded from the App Store and Nucleobase, Nucleotide and Nucleic Acid Metabolism 7 Google Play
    Hoytema van Konijnenburg et al. Orphanet J Rare Dis (2021) 16:170 https://doi.org/10.1186/s13023-021-01727-2 REVIEW Open Access Treatable inherited metabolic disorders causing intellectual disability: 2021 review and digital app Eva M. M. Hoytema van Konijnenburg1†, Saskia B. Wortmann2,3,4†, Marina J. Koelewijn2, Laura A. Tseng1,4, Roderick Houben6, Sylvia Stöckler‑Ipsiroglu5, Carlos R. Ferreira7 and Clara D. M. van Karnebeek1,2,4,8* Abstract Background: The Treatable ID App was created in 2012 as digital tool to improve early recognition and intervention for treatable inherited metabolic disorders (IMDs) presenting with global developmental delay and intellectual disabil‑ ity (collectively ‘treatable IDs’). Our aim is to update the 2012 review on treatable IDs and App to capture the advances made in the identifcation of new IMDs along with increased pathophysiological insights catalyzing therapeutic development and implementation. Methods: Two independent reviewers queried PubMed, OMIM and Orphanet databases to reassess all previously included disorders and therapies and to identify all reports on Treatable IDs published between 2012 and 2021. These were included if listed in the International Classifcation of IMDs (ICIMD) and presenting with ID as a major feature, and if published evidence for a therapeutic intervention improving ID primary and/or secondary outcomes is avail‑ able. Data on clinical symptoms, diagnostic testing, treatment strategies, efects on outcomes, and evidence levels were extracted and evaluated by the reviewers and external experts. The generated knowledge was translated into a diagnostic algorithm and updated version of the App with novel features. Results: Our review identifed 116 treatable IDs (139 genes), of which 44 newly identifed, belonging to 17 ICIMD categories.
    [Show full text]
  • A SARS-Cov-2 Protein Interaction Map Reveals Targets for Drug Repurposing
    Article A SARS-CoV-2 protein interaction map reveals targets for drug repurposing https://doi.org/10.1038/s41586-020-2286-9 A list of authors and affiliations appears at the end of the paper Received: 23 March 2020 Accepted: 22 April 2020 A newly described coronavirus named severe acute respiratory syndrome Published online: 30 April 2020 coronavirus 2 (SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has infected over 2.3 million people, led to the death of more than Check for updates 160,000 individuals and caused worldwide social and economic disruption1,2. There are no antiviral drugs with proven clinical efcacy for the treatment of COVID-19, nor are there any vaccines that prevent infection with SARS-CoV-2, and eforts to develop drugs and vaccines are hampered by the limited knowledge of the molecular details of how SARS-CoV-2 infects cells. Here we cloned, tagged and expressed 26 of the 29 SARS-CoV-2 proteins in human cells and identifed the human proteins that physically associated with each of the SARS-CoV-2 proteins using afnity-purifcation mass spectrometry, identifying 332 high-confdence protein–protein interactions between SARS-CoV-2 and human proteins. Among these, we identify 66 druggable human proteins or host factors targeted by 69 compounds (of which, 29 drugs are approved by the US Food and Drug Administration, 12 are in clinical trials and 28 are preclinical compounds). We screened a subset of these in multiple viral assays and found two sets of pharmacological agents that displayed antiviral activity: inhibitors of mRNA translation and predicted regulators of the sigma-1 and sigma-2 receptors.
    [Show full text]
  • Genome-Wide Association Study Identifies Multiple Susceptibility Loci
    ARTICLE Received 8 May 2015 | Accepted 4 Sep 2015 | Published 1 Oct 2015 DOI: 10.1038/ncomms9559 OPEN Genome-wide association study identifies multiple susceptibility loci for glioma Ben Kinnersley1, Marianne Labussie`re2, Amy Holroyd1, Anna-Luisa Di Stefano2,3,4, Peter Broderick1, Jayaram Vijayakrishnan1, Karima Mokhtari2,3,5, Jean-Yves Delattre2,3,4, Konstantinos Gousias6, Johannes Schramm6, Minouk J. Schoemaker1, Sarah J. Fleming7, Stefan Herms8,9, Stefanie Heilmann8, Stefan Schreiber10,11, Heinz-Erich Wichmann12,13, Markus M. No¨then8, Anthony Swerdlow1,14, Mark Lathrop5,15,16, Matthias Simon6, Melissa Bondy17, Marc Sanson2,3,4 & Richard S. Houlston1 Previous genome-wide association studies (GWASs) have shown that common genetic variation contributes to the heritable risk of glioma. To identify new glioma susceptibility loci, we conducted a meta-analysis of four GWAS (totalling 4,147 cases and 7,435 controls), with imputation using 1000 Genomes and UK10K Project data as reference. After genotyping an additional 1,490 cases and 1,723 controls we identify new risk loci for glioblastoma (GBM) at 12q23.33 (rs3851634, near POLR3B, P ¼ 3.02 Â 10 À 9) and non-GBM at 10q25.2 (rs11196067, near VTI1A, P ¼ 4.32 Â 10 À 8), 11q23.2 (rs648044, near ZBTB16, P ¼ 6.26 Â 10 À 11), 12q21.2 (rs12230172, P ¼ 7.53 Â 10 À 11) and 15q24.2 (rs1801591, near ETFA, P ¼ 5.71 Â 10 À 9). Our findings provide further insights into the genetic basis of the different glioma subtypes. 1 Division of Genetics and Epidemiology, The Institute of Cancer Research, London SM2 5NG, UK.
    [Show full text]
  • Loss of TLE3 Promotes the Mitochondrial Program in Beige Adipocytes and Improves Glucose Metabolism
    Downloaded from genesdev.cshlp.org on October 7, 2021 - Published by Cold Spring Harbor Laboratory Press Loss of TLE3 promotes the mitochondrial program in beige adipocytes and improves glucose metabolism Stephanie Pearson,1 Anne Loft,2 Prashant Rahbhandari,3 Judith Simcox,1 Sanghoon Lee,1 Peter Tontonoz,3 Susanne Mandrup,2 and Claudio J. Villanueva1 1Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, Utah 84112, USA; 2Department of Biochemistry and Molecular Biology, University of Southern Denmark, 5230 Odense M, Denmark; 3Department of Pathology and Laboratory Medicine, University of California at Los Angeles, Los Angeles, California 90095, USA Prolonged cold exposure stimulates the recruitment of beige adipocytes within white adipose tissue. Beige adipo- cytes depend on mitochondrial oxidative phosphorylation to drive thermogenesis. The transcriptional mechanisms that promote remodeling in adipose tissue during the cold are not well understood. Here we demonstrate that the transcriptional coregulator transducin-like enhancer of split 3 (TLE3) inhibits mitochondrial gene expression in beige adipocytes. Conditional deletion of TLE3 in adipocytes promotes mitochondrial oxidative metabolism and increases energy expenditure, thereby improving glucose control. Using chromatin immunoprecipitation and deep sequencing, we found that TLE3 occupies distal enhancers in proximity to nuclear-encoded mitochondrial genes and that many of these binding sites are also enriched for early B-cell factor (EBF) transcription factors. TLE3 interacts with EBF2 and blocks its ability to promote the thermogenic transcriptional program. Collectively, these studies demonstrate that TLE3 regulates thermogenic gene expression in beige adipocytes through inhibition of EBF2 transcriptional activity. Inhibition of TLE3 may provide a novel therapeutic approach for obesity and diabetes.
    [Show full text]
  • Parental-To-Embryo Switch of Chromosome Organization in Early
    Parental-to-embryo switch of chromosome organization in early embryogenesis Samuel Collombet, Noemie Ranisavljevic, Takashi Nagano, Csilla Varnai, Tarak Shisode, Wing Leung, Tristan Piolot, Rafael Galupa, Maud Borensztein, Nicolas Servant, et al. To cite this version: Samuel Collombet, Noemie Ranisavljevic, Takashi Nagano, Csilla Varnai, Tarak Shisode, et al.. Parental-to-embryo switch of chromosome organization in early embryogenesis. Nature, Nature Pub- lishing Group, 2020, 580, pp.142 - 146. 10.1038/s41586-020-2125-z. hal-03027197 HAL Id: hal-03027197 https://hal.archives-ouvertes.fr/hal-03027197 Submitted on 27 Nov 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Article Parental-to-embryo switch of chromosome organization in early embryogenesis https://doi.org/10.1038/s41586-020-2125-z Samuel Collombet1,2,10, Noémie Ranisavljevic1,3,10, Takashi Nagano4,9,10, Csilla Varnai4,5, Tarak Shisode6, Wing Leung4,9, Tristan Piolot1, Rafael Galupa1,2, Maud Borensztein1, Received: 3 April 2019 Nicolas Servant7, Peter Fraser4,8,11 ✉, Katia Ancelin1,11 ✉ & Edith Heard1,2,11 ✉ Accepted: 16 January 2020 Published online: 25 March 2020 Paternal and maternal epigenomes undergo marked changes after fertilization1. Recent Check for updates epigenomic studies have revealed the unusual chromatin landscapes that are present in oocytes, sperm and early preimplantation embryos, including atypical patterns of histone modifcations2–4 and diferences in chromosome organization and accessibility, both in gametes5–8 and after fertilization5,8–10.
    [Show full text]